Harvard Bioscience Inc (HBIO)
3.60
+0.04
(+1.12%)
USD |
NASDAQ |
Apr 26, 16:00
3.60
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Cash from Investing (TTM): -1.799M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.799M |
| September 30, 2023 | -0.973M |
| June 30, 2023 | -1.014M |
| March 31, 2023 | -0.831M |
| December 31, 2022 | -1.59M |
| September 30, 2022 | -1.713M |
| June 30, 2022 | -1.751M |
| March 31, 2022 | -1.515M |
| December 31, 2021 | -1.345M |
| September 30, 2021 | -1.301M |
| June 30, 2021 | -1.385M |
| March 31, 2021 | -1.462M |
| December 31, 2020 | -1.402M |
| September 30, 2020 | -1.544M |
| June 30, 2020 | -1.341M |
| March 31, 2020 | -0.318M |
| December 31, 2019 | -0.229M |
| September 30, 2019 | -0.40M |
| June 30, 2019 | -0.296M |
| March 31, 2019 | -1.759M |
| December 31, 2018 | -53.80M |
| September 30, 2018 | -53.37M |
| June 30, 2018 | -53.35M |
| March 31, 2018 | -52.88M |
| December 31, 2017 | -0.917M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.176M |
| June 30, 2017 | -0.126M |
| March 31, 2017 | -0.085M |
| December 31, 2016 | -0.062M |
| September 30, 2016 | -1.634M |
| June 30, 2016 | -1.759M |
| March 31, 2016 | -2.133M |
| December 31, 2015 | -7.517M |
| September 30, 2015 | -19.21M |
| June 30, 2015 | -19.02M |
| March 31, 2015 | -18.94M |
| December 31, 2014 | -13.52M |
| September 30, 2014 | -1.606M |
| June 30, 2014 | 0.144M |
| March 31, 2014 | 0.356M |
| December 31, 2013 | 0.171M |
| September 30, 2013 | -0.069M |
| June 30, 2013 | -1.845M |
| March 31, 2013 | -2.358M |
| December 31, 2012 | -4.676M |
| September 30, 2012 | -4.726M |
| June 30, 2012 | -9.68M |
| March 31, 2012 | -9.32M |
| December 31, 2011 | -7.198M |
| September 30, 2011 | -7.712M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.799M
Minimum
Dec 2023
-0.229M
Maximum
Dec 2019
-1.169M
Average
-1.345M
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
| Bruker Corp | -326.00M |
| Azenta Inc | 473.42M |
| Bionano Genomics Inc | 24.16M |
| Akoya Biosciences Inc | 3.347M |
| Singular Genomics Systems Inc | 13.81M |